Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

5-HT4 receptor ligands studied extensively at Roche Bioscience

Aug. 30, 1999

Incara subsidiary licenses rights to liver progenitor cell technology

Aug. 30, 1999

Tanabe Seiyaku pursues integrin receptor antagonists, with interesting results

Aug. 25, 1999

FDA approves Aciphex for treatment of GERD and duodenal ulcers

Aug. 23, 1999

Remicade receives E.U. approval for Crohn's disease treatment

Aug. 19, 1999

Preclinical study results indicate efficacy of thiazolidinediones in IBD

Aug. 16, 1999

FDA approves injectable, oral formulations of Wyeth-Ayerst's Protonix

Aug. 6, 1999

Anti-H. pylori agents isolated from natural source by Takeda team

Aug. 6, 1999

Zeffix approved in E.U. for chronic HBV

Aug. 3, 1999

PA153, a novel agent for the diagnosis and treatment of pancreatic diseases

Aug. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...